Table 1.
Patient and Tumor Characteristics
| Age, y (mean ± SD) | 58.5 ± 14.9 |
| Sex, n (%) | |
| Male | 21 (56.8) |
| Female | 16 (43.2) |
| Eye, n (%) | |
| Right | 21 (56.8) |
| Left | 16 (43.2) |
| Ciliary body involvement, n (%) | |
| Not present | 21 (56.8) |
| Present | 16 (43.2) |
| Largest basal diameter, mm (mean ± SD) | 13.4 ± 3.0 |
| Prominence, mm (mean ± SD) | 7.1 ± 2.7 |
| Tumor size according pTNM (7th edition), n (%) | |
| T1 | 4 (11.1) |
| T2 | 11 (30.6) |
| T3 | 20 (55.6) |
| T4 | 1 (2.8) |
| Cell type, n (%) | |
| Spindle | 9 (24.3) |
| Mixed + Epithelioid | 28 (75.7) |
| Macrophage Density (IHC), n (%) | |
| Low | 12 (32.4) |
| Medium | 15 (40.5) |
| High | 10 (27.0) |
| Microvascular density, n (%) | |
| First quartile | 10 (27.0) |
| Second quartile | 9 (24.3) |
| Third quartile | 7 (18.9) |
| Fourth quartile | 11 (29.7) |
| Chromosome 3 status, n (%) | |
| Disomy | 13 (35.1) |
| Monosomy | 24 (64.9) |
| HC10, % of tumor cells (mean ± SD) | 44.2 ± 32.8 |
| HCA2, % of tumor cells (mean ± SD) | 46.5 ± 31.7 |
| HLA-DR, % of tumor cells (mean ± SD) | 20.3 ± 21.3 |
| Follow-up, y (mean ± SD) | 4.8 ± 2.3 |
| Metastasis, n (%) | |
| Not present | 22 (59.5) |
| Present | 15 (40.5) |
| Survival status, n (%) | |
| Alive | 17 (45.9) |
| Death due to metastasis | 15 (40.5) |
| Death due to other causes | 5 (13.5) |